High-risk liver patients are not associated with adverse events following pancreaticoduodenectomy. Mangieri CW, Strode MA, Valenzuela CD, Erali RA, et al. Am J Surg 2022 Nov 13:S0002-9610(22)00717-6. doi: 10.1016/j.amjsurg.2022.

Read + Share

Amedeo Smart

Independent Medical Education

Mangieri CW, Strode MA, Valenzuela CD, Erali RA, et al. High-risk liver patients are not associated with adverse events following pancreaticoduodenectomy. Am J Surg 2022 Nov 13:S0002-9610(22)00717-6. doi: 10.1016/j.amjsurg.2022.
PMID: 36428108